Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions
| Autor: | Pierre Singer, Geert J. A. Wanten, Berthold Koletzko, Gordon L. Jensen, Phillip C. Calder |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
Resuscitation Fat Emulsions Intravenous Parenteral Nutrition Calorie Critical Illness Clinical nutrition Review Critical Care and Intensive Care Medicine Intensive care Anesthesiology medicine Lipid emulsion otorhinolaryngologic diseases Humans Energy deficit Molecular gastro-enterology and hepatology [IGMD 2] Intensive care medicine Critically ill business.industry Fatty acid Intensive Care Units Parenteral nutrition business Forecasting |
| Zdroj: | Intensive Care Medicine Intensive Care Medicine, 36, 5, pp. 735-49 Intensive Care Medicine, 36, 735-49 |
| ISSN: | 0342-4642 |
| DOI: | 10.1007/s00134-009-1744-5 |
| Popis: | Item does not contain fulltext BACKGROUND: Energy deficit is a common and serious problem in intensive care units and is associated with increased rates of complications, length of stay, and mortality. Parenteral nutrition (PN), either alone or in combination with enteral nutrition, can improve nutrient delivery to critically ill patients. Lipids provide a key source of calories within PN formulations, preventing or correcting energy deficits and improving outcomes. DISCUSSION: In this article, we review the role of parenteral lipid emulsions (LEs) in the management of critically ill patients and highlight important biologic activities associated with lipids. Soybean-oil-based LEs with high contents of polyunsaturated fatty acids (PUFA) were the first widely used formulations in the intensive care setting. However, they may be associated with increased rates of infection and lipid peroxidation, which can exacerbate oxidative stress. More recently developed parenteral LEs employ partial substitution of soybean oil with oils providing medium-chain triglycerides, omega-9 monounsaturated fatty acids or omega-3 PUFA. Many of these LEs have demonstrated reduced effects on oxidative stress, immune responses, and inflammation. However, the effects of these LEs on clinical outcomes have not been extensively evaluated. CONCLUSIONS: Ongoing research using adequately designed and well-controlled studies that characterize the biologic properties of LEs should assist clinicians in selecting LEs within the critical care setting. Prescription of PN containing LEs should be based on available clinical data, while considering the individual patient's physiologic profile and therapeutic requirements. 01 mei 2010 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink